DN

Dragan Nebrigic

Chief Operating Officer

Vigilant Biosciences, Inc.

Austin, Texas


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Vigilant Biosciences, Inc.
Industry
research
Employees
20.0
Seniority
C suite
Annual Revenue
5000000.0
Total Funding
16901450.0
Latest Funding
Other

Technologies

Outlook WP Engine Hubspot Linkedin Marketing Solutions Facebook Custom Audiences Facebook Login (Connect) Mobile Friendly Google Tag Manager Google Font API Facebook Widget WordPress.org Remote AI

Keywords

biotechnology oncology diagnostics biotechnology research oral cancer screening early detection bevigilant orafusion system point-of-care test biomarker detection fda breakthrough device clinical risk factors innovative technology salivary biomarkers immunoassays risk assessment non-invasive test real-time results patient outcomes survival rates cancer diagnostics patient education dentistry healthcare innovation cancer care improvement clinical expertise sensitive detection diagnostic accuracy saliva test biomarker identification oral abnormalities screening process healthcare solutions early intervention clinical resources patient resources provider resources partnerships in healthcare biomedical innovation cutting-edge technology healthcare partnership oral health smoking & cancer risk alcohol & cancer risk hpv & cancer detection methods cancer stage diagnostics patient engagement training & certification product availability market expansion health awareness hospital & health care medical practice

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans